Engeletin alleviates cerebral ischemia reperfusion‐induced neuroinflammation via the HMGB1 / TLR4 / NF‐κB network
Journal of Cellular and Molecular Medicine · 2023-06 · 27 (12) · 1653-1663
DOI: 10.1111/jcmm.17758 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, online erschienen am 02.05.2023. Verfasst von Yangyang Xu und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation…. Hauptthemen laut MEDLINE: HMGB1 Protein, Brain Ischemia, Reperfusion Injury. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Project of Shandong Province Higher Educational Science and Technology Program.
Abstract (Originalsprache)
High‐mobility group box1 (HMGB1) induces inflammatory injury, and emerging reports suggest that it is critical for brain ischemia reperfusion. Engeletin, a natural Smilax glabra rhizomilax derivative, is reported to possess anti‐inflammatory activity. Herein, we examined the mechanism of engeletin‐mediated neuroprotection in rats having transient middle cerebral artery occlusion (tMCAO) against cerebral ischemia reperfusion injury. Male SD rats were induced using a 1.5 h tMCAO, following by reperfusion for 22.5 h. Engeletin (15, 30 or 60 mg/kg) was intravenously administered immediately following 0.5 h of ischemia. Based on our results, engeletin, in a dose‐dependent fashion, reduced neurological deficits, infarct size, histopathological alterations, brain edema and inflammatory factors, namely, circulating IL‐1β, TNF‐α, IL‐6 and IFN‐γ. Furthermore, engeletin treatment markedly reduced neuronal apoptosis, which, in turn, elevated Bcl‐2 protein levels, while suppressing Bax and Cleaved Caspase‐3 protein levels. Meanwhile, engeletin significantly reduces overall expressions of HMGB1, TLR4, and NF‐κB and attenuated nuclear transfer of nuclear factor kappa B (NF‐κB) p65 in ischemic cortical tissue. In conclusion, engeletin strongly prevents focal cerebral ischemia via suppression of the HMGB1/TLR4/NF‐κB inflammatory network.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universi…
- Department of Pharmacy, Binzhou Medical University Hospital, Binzhou, China.
- Department of Radiology, Binzhou Medical University Hospital, Binzhou, China.
- College of Basic Medicine, Binzhou Medical University, Yantai, China.
ORCID-Profile: Yangyang Xu
Förderung
- National Natural Science Foundation of China
- Project of Shandong Province Higher Educational Science and Technology Program
Zitieren
APA
Xu, Y., Zhang, J., Gao, F., Cheng, W., Zhang, Y., Wei, C., Zhang, S., & Gao, X. (2023). Engeletin alleviates cerebral ischemia reperfusion‐induced neuroinflammation via the HMGB1 / TLR4 / NF‐κB network. Journal of Cellular and Molecular Medicine, 27(12), 1653-1663. https://doi.org/10.1111/jcmm.17758
Vancouver
Xu Y, Zhang J, Gao F, Cheng W, Zhang Y, Wei C, et al. Engeletin alleviates cerebral ischemia reperfusion‐induced neuroinflammation via the HMGB1 / TLR4 / NF‐κB network. Journal of Cellular and Molecular Medicine. 2023;27(12):1653-1663. doi:10.1111/jcmm.17758
BibTeX
@article{Xu2023,
author = {Xu, Yangyang and Zhang, Jie and Gao, Fei and Cheng, Wenna and Zhang, Ye and Wei, Chuanmei and Zhang, Shuping and Gao, Xinfu},
title = {Engeletin alleviates cerebral ischemia reperfusion‐induced neuroinflammation via the HMGB1 / TLR4 / NF‐κB network},
journal = {Journal of Cellular and Molecular Medicine},
year = {2023},
volume = {27},
number = {12},
pages = {1653--1663},
doi = {10.1111/jcmm.17758}
}
EUVIMED